Global Prostate Cancer Clinical Landscape Report 2021: Pfizer’s Next-generation Androgen Receptor (AR) Inhibitor Xtandi is the Market Leader
DUBLIN, July 16, 2021 /PRNewswire/ — The “Disease Analysis: Prostate Cancer” report has been added to ResearchAndMarkets.com’s offering. The publisher estimates that in 2018, there were 1.3 million incident cases of prostate cancer worldwide in males aged 40 years and older, and…
Comments Off on Global Prostate Cancer Clinical Landscape Report 2021: Pfizer’s Next-generation Androgen Receptor (AR) Inhibitor Xtandi is the Market Leader